Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8993 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8993 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8951 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8929 |
High Similarity |
NPD1549 |
Phase 2 |
0.8904 |
High Similarity |
NPD4380 |
Phase 2 |
0.8849 |
High Similarity |
NPD1510 |
Phase 2 |
0.8832 |
High Similarity |
NPD1240 |
Approved |
0.8784 |
High Similarity |
NPD6801 |
Discontinued |
0.8725 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8705 |
High Similarity |
NPD1607 |
Approved |
0.869 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8675 |
High Similarity |
NPD7075 |
Discontinued |
0.8658 |
High Similarity |
NPD1934 |
Approved |
0.8621 |
High Similarity |
NPD1511 |
Approved |
0.8621 |
High Similarity |
NPD6799 |
Approved |
0.86 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8553 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8531 |
High Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8521 |
High Similarity |
NPD2796 |
Approved |
0.8503 |
High Similarity |
NPD1512 |
Approved |
0.8477 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8472 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8467 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8421 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8418 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.84 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8366 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8345 |
Intermediate Similarity |
NPD1243 |
Approved |
0.831 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8235 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8228 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8228 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8228 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.82 |
Intermediate Similarity |
NPD5403 |
Approved |
0.82 |
Intermediate Similarity |
NPD920 |
Approved |
0.8188 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8182 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8176 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8163 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8138 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8125 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8095 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8075 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8067 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8067 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8067 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8067 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8041 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8038 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8028 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8025 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8025 |
Intermediate Similarity |
NPD919 |
Approved |
0.8025 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8013 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7927 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7927 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7925 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7919 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7899 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7898 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7879 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7879 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7862 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7842 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7834 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7801 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7793 |
Intermediate Similarity |
NPD943 |
Approved |
0.7771 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.777 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7764 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7758 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7744 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.774 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7737 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7736 |
Intermediate Similarity |
NPD3749 |
Approved |
0.773 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7718 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7703 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7703 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7703 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7655 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7644 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7643 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7636 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7619 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7619 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7609 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7584 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7551 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7551 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7545 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7534 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7534 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7533 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7533 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7518 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7517 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD2309 |
Approved |
0.75 |
Intermediate Similarity |
NPD447 |
Suspended |
0.75 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7464 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7451 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7448 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7439 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7439 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7434 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7429 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7429 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7415 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7405 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7397 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7397 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7394 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7386 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7379 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7351 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD9494 |
Approved |
0.731 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7308 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7297 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7297 |
Intermediate Similarity |
NPD411 |
Approved |
0.7268 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7267 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7261 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7261 |
Intermediate Similarity |
NPD4662 |
Approved |
0.726 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7255 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7246 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7241 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7237 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.723 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7222 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7216 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7193 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7192 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7192 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7188 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7185 |
Intermediate Similarity |
NPD290 |
Approved |
0.7181 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD2354 |
Approved |
0.717 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7169 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7162 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7153 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7152 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7132 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7127 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7125 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7123 |
Intermediate Similarity |
NPD8651 |
Approved |
0.711 |
Intermediate Similarity |
NPD8312 |
Approved |
0.711 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7107 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7103 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7086 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7075 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7073 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7063 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD4749 |
Approved |
0.705 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7044 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7034 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7032 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7032 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7032 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7032 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7032 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7032 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7032 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7027 |
Intermediate Similarity |
NPD5647 |
Approved |
0.7024 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.702 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7014 |
Intermediate Similarity |
NPD17 |
Approved |
0.7012 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.6994 |
Remote Similarity |
NPD5889 |
Approved |
0.6994 |
Remote Similarity |
NPD5890 |
Approved |
0.6989 |
Remote Similarity |
NPD8434 |
Phase 2 |
0.6986 |
Remote Similarity |
NPD1481 |
Phase 2 |
0.6986 |
Remote Similarity |
NPD9269 |
Phase 2 |
0.6982 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6981 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6974 |
Remote Similarity |
NPD3142 |
Approved |
0.6974 |
Remote Similarity |
NPD3140 |
Approved |
0.6974 |
Remote Similarity |
NPD4307 |
Phase 2 |
0.697 |
Remote Similarity |
NPD2296 |
Approved |
0.6962 |
Remote Similarity |
NPD3887 |
Approved |
0.6959 |
Remote Similarity |
NPD1470 |
Approved |
0.6951
|
Remote Similarity |
NPD37 |
Approved |